Steven D. Gore

Also affiliated with National Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Bringing experimental therapeutics clinical trials network (ETCTN) to underrepresented population.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6542

Top 100%

0DataRank

Top 100%0 citations

Gary C. Doolittle, Rahul Atul Parikh, Anup Kasi, Elizabeth Wulff‐Burchfield, Benjamin Powers +15 more

Papers

Driven by 18 papers — median percentile 0. Top paper: “Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults”.

Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults

New England Journal of Medicine(2024)10.1056/nejmoa2312948

N/A

4.4DataRank · unranked

227 citations

Zhuoxin Sun, Ryan J. Mattison, Elisabeth Paietta, Kathryn G. Roberts, Yanming Zhang +37 more

Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer

JAMA Oncology(2023)10.1001/jamaoncol.2023.4025

N/A

1.1DataRank · unranked

48 citations

Zhonglin Hao, Liza C. Villaruz, Jun Zhang, Jimmy Ruiz, W. Jeffrey Petty +33 more

A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agents

Annals of Hematology(2023)10.1007/s00277-023-05552-4

N/A

0.726DataRank · unranked

23 citations

Rory M. Shallis, Elad Sharon, Silvia Park, Rahul Ramaswamy, Caroline E. Roe +18 more

Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study

Blood Advances(2023)10.1182/bloodadvances.2022009000

N/A

0.697DataRank · unranked

16 citations

Donnie Hebert, Cecilia Lee, Dana E. Rollison, Nancy Gillis, Rami S. Komrokji +15 more

Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies

Blood Advances(2023)10.1182/bloodadvances.2023010061

N/A

0.554DataRank · unranked

12 citations

Michael Otterstatter, Tareq Al Baghdadi, Nancy Gillis, James M. Foran, Jane Jijun Liu +19 more

Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions

Blood Advances(2023)10.1182/bloodadvances.2022008578

N/A

0.543DataRank · unranked

9 citations

Johannes B. Goll, R. Coleman Lindsley, Rafael Bejar, Steffanie H Wilson, Donnie Hebert +20 more

An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS

Blood Advances(2022)10.1182/bloodadvances.2022008747

N/A

0.525DataRank · unranked

11 citations

Omar Abdel-Wahab, Andrew H. Wei, Michael R. Savona, Mina L. Xu, Zhuoer Xie +45 more

Phase Ib study of berzosertib, carboplatin, gemcitabine, and pembrolizumab in patients with squamous nonsmall lung cancer (ETCTN 10313)

The Oncologist(2025)10.1093/oncolo/oyaf373

N/A

0.109DataRank · unranked

1 citations

Benjamin Schluger, Hong Wang, James Ohr, Daniel P. Petro, Alexander D. Fuld +10 more

High-throughput combination screening of Pidnarulex and other G-quadruplex ligands in multi-cell type tumor spheroids

SLAS DISCOVERY(2025)10.1016/j.slasd.2025.100284

N/A

0DataRank · unranked

1 citations

Nathan P. Coussens, Thomas Silvers, Poorva Juneja, Eric A. Jones, Steven D. Gore +4 more

Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia

Blood Advances(2021)10.1182/bloodadvances.2021004916

N/A

0DataRank · unranked

77 citations

Leland Metheny, Mei‐Jie Zhang, Hailin Wang, Noel Estrada‐Merly, David I. Marks +72 more

RNA processing kinase inhibitors and epigenetic inhibitors in combination with oncology drugs or investigational agents in multi-cell type patient-derived tumor cell line spheroids

Cancer Chemotherapy and Pharmacology(2025)10.1007/s00280-025-04800-w

N/A

0DataRank · unranked

0 citations

Thomas S. Dexheimer, Thomas Silvers, Nathan P. Coussens, Eric M. Jones, Steven D. Gore +3 more

Challenges in the Evaluation and Management of Toxicities Arising From Immune Checkpoint Inhibitor Therapy for Patients With Myeloid Malignancies

Clinical Lymphoma Myeloma & Leukemia(2021)10.1016/j.clml.2021.01.003

N/A

0DataRank · unranked

1 citations

Jan Philipp Bewersdorf, David M. Swoboda, Wei Wei, Lohith Gowda, Thomas Prébet +10 more

Bringing experimental therapeutics clinical trials network (ETCTN) to underrepresented population.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6542

Top 100%

0DataRank

Top 100%0 citations

Gary C. Doolittle, Rahul Atul Parikh, Anup Kasi, Elizabeth Wulff‐Burchfield, Benjamin Powers +15 more

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)

Blood Reviews(2023)10.1016/j.blre.2023.101128

N/A

0DataRank · unranked

31 citations

Jan Philipp Bewersdorf, Zhuoer Xie, Matteo Giovanni Della Porta, Rami S. Komrokji, Mina L. Xu +43 more

Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)

Blood Reviews(2023)10.1016/j.blre.2023.101072

N/A

0DataRank · unranked

18 citations

Zhuoer Xie, Rafael Bejar, Uma Borate, Jacqueline Boultwood, Andrew M. Brunner +37 more

PD-1H/VISTA mediates immune evasion in acute myeloid leukemia

Journal of Clinical Investigation(2023)10.1172/jci164325

N/A

0DataRank · unranked

18 citations

Xue Han, Qianni Hu, Esten N. Vandsemb, Carly M. Fielder, Junshik Hong +21 more

A phase 2 single-arm study of berzosertib in combination with irinotecan in patients with progressive TP53 mutant gastric and gastro-esophageal junction cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4044

N/A

0DataRank · unranked

4 citations

Heloisa P. Soares, Farshid Dayyani, Anwaar Saeed, Edward S. Kim, Ning Jin +7 more

Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes—Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])

Modern Pathology(2024)10.1016/j.modpat.2024.100615

N/A

0DataRank · unranked

12 citations

Savanah D. Gisriel, Amer M. Zeidan, John M. Bennett, Rafael Bejar, Jan Philipp Bewersdorf +48 more

Steven D. Gore

Indexed papers

Top data-sharing exemplar

Papers